{"id":"W2899084046","doi":"10.3233/jpd-181471","title":"A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein","year":2018,"lang":"en","type":"article","venue":"Journal of Parkinson s Disease","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health; H. Lundbeck A/S; Eisai; Agence Nationale de la Recherche; University of Cambridge; University of British Columbia; Axial Biotherapeutics; European Commission; Acorda Therapeutics; Weston Brain Institute; Sunovion; Robert Bosch Stiftung; GlaxoSmithKline; Teva Pharmaceutical Industries; Michael J. Fox Foundation for Parkinson's Research; American Academy of Neurology; AstraZeneca","keywords":"Parkinson's disease; Clinical trial; Synucleinopathies; Alpha-synuclein; Translational research; Disease; Medicine; Drug development; Biomarker discovery; Biomarker; Clinical study design; Bioinformatics; Pathology; Biology; Pharmacology; Proteomics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005460015,0.0005543947,0.002183922,0.0003547272,0.0002809866,0.00008872421,0.000393933,0.0001802466,0.0002182355],"category_scores_gemma":[0.01134445,0.0004224998,0.001821724,0.0003620967,0.0006261587,0.0003638761,0.0001038735,0.0004012565,0.000010348],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002076966,"about_ca_system_score_gemma":0.002219441,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001053361,"about_ca_topic_score_gemma":0.000002342385,"domain_scores_codex":[0.9925275,0.001215462,0.003674382,0.0006872009,0.001214095,0.0006813789],"domain_scores_gemma":[0.9898942,0.000955599,0.003869473,0.0006001216,0.001480608,0.003199977],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.06165681,0.01629248,0.7543333,0.002616246,0.005631371,0.002254531,0.001296176,0.00008376662,0.0118658,0.0009212138,0.06514525,0.07790305],"study_design_scores_gemma":[0.05173035,0.009676999,0.4040685,0.004396413,0.01201419,0.00007804179,0.0007163031,0.01137986,0.03358189,0.007632798,0.463344,0.001380624],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984704,0.004933253,0.003827543,0.001771006,0.001310959,0.002690932,0.0005654314,0.00006218549,0.0001346904],"genre_scores_gemma":[0.9838826,0.0000946652,0.01191898,0.0009212318,0.002769836,0.00007645355,0.00009730613,0.0001051439,0.0001337519],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3981988,"threshold_uncertainty_score":0.9998227,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1209460531511432,"score_gpt":0.4036362395024081,"score_spread":0.282690186351265,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}